The National Institutes of Health said this week that it is funding 4 projects dedicated to testing fully automated artificial pancreas devices in patients with Type I diabetes.
The race to develop an artificial pancreas met a milestone last year, after the FDA approved Medtronic’s (NYSE:MDT) hybrid model of an artificial pancreas – the 1st of its kind to win global clearance.
Get the full story at our sister site, Drug Delivery Business News.
The post NIH launches pivotal trials for artificial pancreas appeared first on MassDevice.